(Q39866696)

15 September 2017

1 reference

title

Complications of radioiodine treatment of hyperthyroidism (English)

1 reference

15 September 2017

Becker DV

1

1 reference

15 September 2017

Hurley JR

series ordinal

2

1 reference

15 September 2017

publication date

1 October 1971

1 reference

Seminars in Nuclear Medicine

15 September 2017

published in

1 reference

15 September 2017

volume

1

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

442-460

1 reference

Treatment of Graves' disease with radioactive iodine

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Treatment of hyperthyroidism with radioactive iodine; I130, 12-hour half-life and I131, 8-day half-life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Hyperthyroidism treated with radioiodine; a seven-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Treatment of toxic nodular goitre with radioactive iodine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Fractionated 131-I therapy in large toxic goitres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

The thyroid gland after treatment of hyperthyroidism by partial thyroidectomy or iodine 131

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

ABNORMAL IODOPROTEINS IN SERUM: SEPARATION BY GEL FILTRATION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Iodine metabolism in a case of thyrotoxic crisis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

[Radioiodine 131 in therapy of hyperthyroidism.]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

When and how to use higher 131-I doses for hyperthyroidism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Treatment of toxic nodular and diffuse goitre with radioactive iodine. Late results and use of carbimazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Radioactive iodine, I-131, in the treatment of hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Treatment of thyrotoxicosis with 131 I; a review of 500 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

The use of radioactive iodine in the diagnosis and treatment of hyperthyroidism: ten years' experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Maximum utilization of the life table method in analyzing survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Incidence of hypothyroidism and recurrences following I-131 treatment of hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Hypothyroidism following 131-I treatment for hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

The treatment of hyperthyroidism with radioactive iodine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Radioactive iodine in the treatment of hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Results in the treatment of hyperthyroidism with radioiodine, I131

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Oak Ridge radioiodine (I131) for hyperthyroidism; tenth anniversary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Myxedema following radioactive iodine therapy of hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

RISING INCIDENCE OF HYPOTHYROIDISM AFTER RADIOACTIVE-IODINE THERAPY IN THYROTOXICOSIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

THYROTOXICOSIS TREATED BY SURGERY OR IODINE-131. WITH SPECIAL REFERENCE TO DEVELOPMENT OF HYPOTHYROIDISM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Clinical trial of different doses of 131-I in treatment of thyrotoxicosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

A critical analysis of the quantitative I131 therapy of thyrotoxicosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Comparison of high and low dosage levels of 131-I in the treatment of thyrotoxicosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Effect of pretreatment with methylthiouracil on results of I-131 therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

RADIOIODINE THERAPY IN THYROTOXICOSIS; A REVIEW OF 908 CASES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Random dosage of 131-I in the treatment of hyperthyroidism: results of a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Delay in Control of Thyrotoxicosis After Treatment with Radioactive Iodine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Delay in Control of131I-Treated Thyrotoxicosis Is Avoidable

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Induction of myxedema by iodide in patients euthyroid after radioiodin or surgical treatment of diffuse toxic goiter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

A quantitative autoradiographic study of radioiodine distribution and dosage in human thyroid glands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

PROBLEM OF HYPOTHYROIDISM AFTER I131 THERAPY OF HYPERTHYROIDISM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Thyroid Antibodies in Euthyroid Subjects after Iodine-131 Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Radiation, Thyroid Cells and131I Therapy—A Hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Treatment of thyrotoxicosis with ionising radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

A follow-up scheme for detecting hypothyroidism in thyrotoxic patients treated with radioiodine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

131-I treatment for thyrotoxicosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

The use of a computer in patient follow-up in Scotland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Temporary hypoparathyroidism following radioactive iodine treatment for thyrotoxicosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Hypoparathyroidism following radioactive iodine therapy for intractable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Hypoparathyroidism following 131-I therapy for hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

THE METABOLISM OF BIOLOGICALLY IMPORTANT RADIONUCLIDES. V. THE METABOLISM OF RADIOIODINE AND RADIATION DOSAGE IN MAN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

The pathologic effects of I131 on the normal thyroid gland of man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Plasma levels of ionised calcium and magnesium in thyroid disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Idiopathic hypoparathyroidism associated with hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Investigation of post-thyroidectomy patients for hypoparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Prevalence of parathyroid insufficiency after thyroidectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Mechanism of hypocalcaemia after thyroidectomy for thyrotoxicosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Parathyroid function in spontaneous primary hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Polypeptide hormones and calcium metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Evidence for Thyrocalcitonin in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Plasma-calcitonin in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Radiation risk: a scientific problem?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Blood radiation dose after 131-I therapy of thyrotoxicosis. Calculations with reference to leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Leukaemia following radioiodine treatment of thyrotoxicosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Incidence of leukemia following treatment of hyperthyroidism. Preliminary report of the Cooperative Thyrotoxicosis Therapy Follow-Up Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Risk of thyroid neoplasms after irradiation in childhood. Studies of populations exposed to radiation in childhood show a dose response over a wide dose range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Thyroid nodules occurring late after treatment of thyrotoxicosis with radioiodine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Thyroid carcinoma in atomic bomb survivors Hiroshima and Nagasaki,

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

FOLLOW-UP STUDY OF ADULTS TREATED WITH ROENTGEN RAYS FOR THYROID DISEASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Sensitivity of the weanling rat thyroid to radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

The Risk of Thyroid Cancers Following Irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Anaplastic thyroid cancer twelve years after radioiodine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Thyroid cancer after irradiation in adult life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Estimates of gonad and genetically significant dose to the United States population from diagnostic roentgenology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Lymphocyte chromosomes in untreated and 131-I-treated thyrotoxic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

CHROMOSOME ABERRATIONS IN RADIATION WORKERS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

IN VIVO EFFECTS OF DIAGNOSTIC X-IRRADIATION ON HUMAN CHROMOSOMES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

Serum thyroxine in the early phase of subacute thyroiditis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Hypothyroidism following treatment of thyrotoxicosis with radioiodine

1 reference

https://api.crossref.org/works/10.1016%2FS0001-2998%2871%2981039-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0001-2998(71)81039-5

1 reference

15 September 2017

1 reference